Stop wasting hours on dense SEC filings. Get AI-powered summaries of any SEC Filings in seconds. Understand key insights and risks, fast.
Currently we only process Form 8-K, 6-K, 3, 4, 144, Schedule 13D and Schedule 13G. We will support more forms in the future.
Filter by Form Type:
Industry:Biotechnologyβ
2026-05-01ORKA144LAURA SANDLER plan to sell securities of ORUKA THERAPEUTICS INC under Form 144MEDIUM
LAURA SANDLER filed Form 144 to notify SEC of plan to sell 10000 units of ORUKA THERAPEUTICS INC securities around 2026-05-01, with aggregate market value of $684,100.00. The total outstanding units is 49542691.0. The amount planned to be sold represents 0.02% of total outstanding units; Recent transactions in past 3 m...
Mid CapBiotechnology
2026-05-01FENC144ROSTISLAV RAYKOV plan to sell securities of FENNEC PHARMACEUTICALS INC. under Form 144MEDIUM
ROSTISLAV RAYKOV filed Form 144 to notify SEC of plan to sell 10781 units of FENNEC PHARMACEUTICALS INC. securities around 2026-05-01, with aggregate market value of $69,761.69. The total outstanding units is 34475178.0. The amount planned to be sold represents 0.03% of total outstanding units; Recent transactions in p...
Micro CapBiotechnology
2026-05-01NRIX144CHRISTINE RING plan to sell securities of NURIX THERAPEUTICS INC under Form 144MEDIUM
CHRISTINE RING filed Form 144 to notify SEC of plan to sell 5394 units of NURIX THERAPEUTICS INC securities around 2026-05-01, with aggregate market value of $90,079.80. The total outstanding units is 103405813.0. The amount planned to be sold represents 0.01% of total outstanding units; Recent transactions in past 3 m...
Small CapBiotechnology